0 Ratings
ID

24355

Description

Study part: Study Conclusion Week 52.An Open-Label Extension phase 3 Study with REQUIP (ropinirole) CR for Subjects from Studies 101468/165, 101468/168 and 101468/169 Patient Level Data. Study ID:101468/248, Clinical Study ID: 101468/248.

Keywords

Versions (1)
  1. 7/30/17 7/30/17 -
Copyright Holder

GlaxoSmithKline

Uploaded on

July 30, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Study Conclusion Week 52 Ropinirole NCT00632736

    English

    Study Conclusion Week 52

    1 forms  
    STUDY CONCLUSION
    Description

    STUDY CONCLUSION

    Alias
    UMLS CUI-1
    C1707478
    UMLS CUI-2
    C0008972
    The study conclusion page completed?
    Description

    Study conclusion

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C1707478
    UMLS CUI [1,2]
    C0008972
    Back to the top of the page

    Similar models

    Study Conclusion Week 52

    1 forms
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    STUDY CONCLUSION
    C1707478 (UMLS CUI-1)
    C0008972 (UMLS CUI-2)
    Study conclusion
    Item
    The study conclusion page completed?
    boolean
    C1707478 (UMLS CUI [1,1])
    C0008972 (UMLS CUI [1,2])
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial